Cargando…

Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release

BACKGROUND: The treatment of patients with multiple trauma including blunt chest/thoracic trauma (TxT) and hemorrhagic shock (H) is still challenging. Numerous studies show detrimental consequences of TxT and HS resulting in strong inflammatory changes, organ injury and mortality. Additionally, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Nils, Dieteren, Scott, Franz, Niklas, Köhler, Kernt, Mörs, Katharina, Nicin, Luka, Schmidt, Julia, Perl, Mario, Marzi, Ingo, Relja, Borna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805235/
https://www.ncbi.nlm.nih.gov/pubmed/29420582
http://dx.doi.org/10.1371/journal.pone.0192171
_version_ 1783298932157186048
author Wagner, Nils
Dieteren, Scott
Franz, Niklas
Köhler, Kernt
Mörs, Katharina
Nicin, Luka
Schmidt, Julia
Perl, Mario
Marzi, Ingo
Relja, Borna
author_facet Wagner, Nils
Dieteren, Scott
Franz, Niklas
Köhler, Kernt
Mörs, Katharina
Nicin, Luka
Schmidt, Julia
Perl, Mario
Marzi, Ingo
Relja, Borna
author_sort Wagner, Nils
collection PubMed
description BACKGROUND: The treatment of patients with multiple trauma including blunt chest/thoracic trauma (TxT) and hemorrhagic shock (H) is still challenging. Numerous studies show detrimental consequences of TxT and HS resulting in strong inflammatory changes, organ injury and mortality. Additionally, the reperfusion (R) phase plays a key role in triggering inflammation and worsening outcome. Ethyl pyruvate (EP), a stable lipophilic ester, has anti-inflammatory properties. Here, the influence of EP on the inflammatory reaction and liver injury in a double hit model of TxT and H/R in rats was explored. METHODS: Female Lewis rats were subjected to TxT followed by hemorrhage/H (60 min, 35±3 mm Hg) and resuscitation/R (TxT+H/R). Reperfusion was performed by either Ringer`s lactated solution (RL) alone or RL supplemented with EP (50 mg/kg). Sham animals underwent all surgical procedures without TxT+H/R. After 2h, blood and liver tissue were collected for analyses, and survival was assessed after 24h. RESULTS: Resuscitation with EP significantly improved haemoglobin levels and base excess recovery compared with controls after TxT+H/R, respectively (p<0.05). TxT+H/R-induced significant increase in alanine aminotransferase levels and liver injury were attenuated by EP compared with controls (p<0.05). Local inflammation as shown by increased gene expression of IL-6 and ICAM-1, enhanced ICAM-1 and HMGB1 protein expression and infiltration of the liver with neutrophils were also significantly attenuated by EP compared with controls after TxT+H/R (p<0.05). EP significantly reduced TxT+H/R-induced p65 activation in liver tissue. Survival rates improved by EP from 50% to 70% after TxT+H/R. CONCLUSIONS: These data support the concept that the pronounced local pro-inflammatory response in the liver after blunt chest trauma and hemorrhagic shock is associated with NF-κB. In particular, the beneficial anti-inflammatory effects of ethyl pyruvate seem to be regulated by the HMGB1/NF-κB axis in the liver, thereby, restraining inflammatory responses and liver injury after double hit trauma in the rat.
format Online
Article
Text
id pubmed-5805235
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58052352018-02-23 Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release Wagner, Nils Dieteren, Scott Franz, Niklas Köhler, Kernt Mörs, Katharina Nicin, Luka Schmidt, Julia Perl, Mario Marzi, Ingo Relja, Borna PLoS One Research Article BACKGROUND: The treatment of patients with multiple trauma including blunt chest/thoracic trauma (TxT) and hemorrhagic shock (H) is still challenging. Numerous studies show detrimental consequences of TxT and HS resulting in strong inflammatory changes, organ injury and mortality. Additionally, the reperfusion (R) phase plays a key role in triggering inflammation and worsening outcome. Ethyl pyruvate (EP), a stable lipophilic ester, has anti-inflammatory properties. Here, the influence of EP on the inflammatory reaction and liver injury in a double hit model of TxT and H/R in rats was explored. METHODS: Female Lewis rats were subjected to TxT followed by hemorrhage/H (60 min, 35±3 mm Hg) and resuscitation/R (TxT+H/R). Reperfusion was performed by either Ringer`s lactated solution (RL) alone or RL supplemented with EP (50 mg/kg). Sham animals underwent all surgical procedures without TxT+H/R. After 2h, blood and liver tissue were collected for analyses, and survival was assessed after 24h. RESULTS: Resuscitation with EP significantly improved haemoglobin levels and base excess recovery compared with controls after TxT+H/R, respectively (p<0.05). TxT+H/R-induced significant increase in alanine aminotransferase levels and liver injury were attenuated by EP compared with controls (p<0.05). Local inflammation as shown by increased gene expression of IL-6 and ICAM-1, enhanced ICAM-1 and HMGB1 protein expression and infiltration of the liver with neutrophils were also significantly attenuated by EP compared with controls after TxT+H/R (p<0.05). EP significantly reduced TxT+H/R-induced p65 activation in liver tissue. Survival rates improved by EP from 50% to 70% after TxT+H/R. CONCLUSIONS: These data support the concept that the pronounced local pro-inflammatory response in the liver after blunt chest trauma and hemorrhagic shock is associated with NF-κB. In particular, the beneficial anti-inflammatory effects of ethyl pyruvate seem to be regulated by the HMGB1/NF-κB axis in the liver, thereby, restraining inflammatory responses and liver injury after double hit trauma in the rat. Public Library of Science 2018-02-08 /pmc/articles/PMC5805235/ /pubmed/29420582 http://dx.doi.org/10.1371/journal.pone.0192171 Text en © 2018 Wagner et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Wagner, Nils
Dieteren, Scott
Franz, Niklas
Köhler, Kernt
Mörs, Katharina
Nicin, Luka
Schmidt, Julia
Perl, Mario
Marzi, Ingo
Relja, Borna
Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release
title Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release
title_full Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release
title_fullStr Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release
title_full_unstemmed Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release
title_short Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release
title_sort ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, nf-kappab activation and hmgb1 release
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805235/
https://www.ncbi.nlm.nih.gov/pubmed/29420582
http://dx.doi.org/10.1371/journal.pone.0192171
work_keys_str_mv AT wagnernils ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release
AT dieterenscott ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release
AT franzniklas ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release
AT kohlerkernt ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release
AT morskatharina ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release
AT nicinluka ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release
AT schmidtjulia ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release
AT perlmario ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release
AT marziingo ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release
AT reljaborna ethylpyruvateameliorateshepaticinjuryfollowingbluntchesttraumaandhemorrhagicshockbyreducinglocalinflammationnfkappabactivationandhmgb1release